SecBot SecBot
8-K ·Filed Feb 25, 2026

MDLN

Medline Inc.
MIXED
Impact 6/10
Horizonweeks Processed8mo ago SEC0002046386-26-000007
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The stock may react positively to strong revenue growth and IPO completion, but investors should monitor whether management can control cost pressures that are eroding profitability. The 2026 guidance suggests continued growth but at potentially compressed margins.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$48.18
T+0 close · Feb 25, 2026 · via day close
Latest settled
−24.76%
T+60 · $36.25
Vs SPY
−31.71%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 25 $48.18entry
  2. T+1 · 9mo ago +1.47%α +2.02% · $48.89
  3. T+5 · 9mo ago −11.00%α −9.90% · $42.88
  4. T+20 · 8mo ago −11.44%α −6.20% · $42.67
  5. T+60 · 6mo ago −24.76%α −31.71% · $36.25
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medline reported strong full-year 2025 revenue growth of 11.5% to $28.4 billion, but net income declined 3.6% to $1.2 billion due to higher costs from tariffs, headcount investments, and IPO-related expenses. Adjusted EBITDA grew 3.2% to $3.5 billion. The company completed its IPO and provided 2026 guidance for organic sales growth of 8-9% and Adjusted EBITDA of $3.5-$3.6 billion.

Key Financial Metrics

Revenue
$28.4K
+11.5% YoY
EPS
$1.42
Free Cash Flow
$1.3K
Gross Margin
26.4%

Key Facts

  • Fourth quarter 2025 net sales: $7.8 billion (+14.8% YoY)
  • Full year 2025 net sales: $28.4 billion (+11.5% YoY)
  • Fourth quarter 2025 net income: $180 million (-37.7% YoY)
  • Full year 2025 net income: $1.2 billion (-3.6% YoY)
  • Full year 2025 Adjusted EBITDA: $3.5 billion (+3.2% YoY)
  • Completed IPO in Q4 2025
  • 2026 guidance: 8-9% organic sales growth and $3.5-$3.6 billion Adjusted EBITDA

Financial Impact

Revenue growth of 11.5% with declining profitability due to cost pressures

revenuenet incomeepsmarginsguidance

Segment Breakdown

SegmentRevenueGrowth
Medline Brand$13.7K+9.6%
Supply Chain Solutions$14.7K+13.2%

Risk Factors

  • Continued margin pressure from tariffs and operating costs
  • Integration costs from acquisitions
  • Execution risk on IPO-related growth initiatives

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0002046386-26-000007
Document: mdln-20260225.htm0002046386-26-000007
Document: 0002046386-26-000007-index-headers.html0002046386-26-000007
Document: 0002046386-26-000007-index.html0002046386-26-000007
Document: 0002046386-26-000007.txt0002046386-26-000007

Track record

30 reports on MDLN

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.17 −7.61% settles Nov 23
  2. Nov 16, 2026today S-1 Neutral 4/10 Entry price pending
  3. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  4. Nov 13, 20263d ago 144 Neutral 2/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  5. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $39.17 −3.78% ▼ −3.78% −2.09% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  7. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.17 −2.92% ▲ +4.49% +5.40% vs SPY
  8. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.17 −14.90% ▼ −20.01% −20.59% vs SPY
  9. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.17 +21.95% ▲ +23.41% +26.12% vs SPY
  10. Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.17 −12.30% ▲ +8.26% +8.96% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (9h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 25, 2026